MBCL-37. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH CLASSIC (CLMB) OR ANAPLASTIC/LARGE CELL (A/LCMB) MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS

Authors: Jonathan Finlay, Martin Mynarek, Girish Dhall, Claire Mazewski, Richard Grundy, Bruce H Cohen, Giles Robinson, David Ashley, Joseph R Stanek, Amar Gajjar, Stefan Rutkowski

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.513

Source: Full article

MBCL-37. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH CLASSIC (CLMB) OR ANAPLASTIC/LARGE CELL (A/LCMB) MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS

Abstract